Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",urine potassium amount,,RS:0000742,WKY,male,0 days,7,,CMO:0000761,urine potassium excretion rate,,,,0.2016,mEq/d,0.0288,0.0762,MMO:0000435,urine potassium analysis,,0.0,,PA IV 50mg/kg,15,days,puromycin aminonucleoside (50 mg/kg) ,100509,puromycin aminonucleoside (50 mg/kg) , 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",urine potassium amount,,RS:0000742,WKY,male,0 days,5,,CMO:0000761,urine potassium excretion rate,,,,0.288,mEq/d,0.0864,0.1932,MMO:0000435,urine potassium analysis,,0.0,,PA IV 50mg/kg,15,days,controlled enalapril content drinking water (50 mg/l) (for 22 days) then puromycin aminonucleoside (50 mg/kg) ,100510,controlled enalapril content drinking water (50 mg/l) (for 22 days),puromycin aminonucleoside (50 mg/kg) 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",urine potassium amount,,RS:0000742,WKY,male,0 days,9,,CMO:0000761,urine potassium excretion rate,,,,0.504,mEq/d,0.0432,0.1296,MMO:0000435,urine potassium analysis,,0.0,,PA IV 50mg/kg,,,puromycin aminonucleoside (50 mg/kg) ,100512,puromycin aminonucleoside (50 mg/kg) , 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",urine potassium amount,,RS:0000742,WKY,male,0 days,8,,CMO:0000761,urine potassium excretion rate,,,,0.4896,mEq/d,0.0432,0.1222,MMO:0000435,urine potassium analysis,,0.0,,PA IV 50mg/kg,,,controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) ,100513,controlled enalapril content drinking water (50 mg/l) (for 7 days),puromycin aminonucleoside (50 mg/kg) 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",urine potassium amount,,RS:0000742,WKY,male,0 days,8,,CMO:0000761,urine potassium excretion rate,,,,1.7136,mEq/d,0.3456,0.9775,MMO:0000435,urine potassium analysis,,0.0,,PA IV 50mg/kg,490,days,puromycin aminonucleoside (50 mg/kg) ,100515,puromycin aminonucleoside (50 mg/kg) , 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",urine potassium amount,,RS:0000742,WKY,male,0 days,9,,CMO:0000761,urine potassium excretion rate,,,,2.16,mEq/d,0.2736,0.8208,MMO:0000435,urine potassium analysis,,0.0,,PA IV 50mg/kg,490,days,controlled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) ,100516,controlled enalapril content drinking water (50 mg/l) (for 497 days),puromycin aminonucleoside (50 mg/kg)